Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1982-7-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-6717
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
157
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7076256-Chromosome Mapping,
pubmed-meshheading:7076256-Endocrine System Diseases,
pubmed-meshheading:7076256-Genetic Linkage,
pubmed-meshheading:7076256-HLA Antigens,
pubmed-meshheading:7076256-Humans,
pubmed-meshheading:7076256-Neoplasms, Multiple Primary,
pubmed-meshheading:7076256-Syndrome
|
pubmed:year |
1982
|
pubmed:articleTitle |
Exclusion of linkage between the loci for multiple endocrine neoplasia type-2 (MEN-2) and HLA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|